Annual report pursuant to Section 13 and 15(d)

Income Taxes

v3.22.4
Income Taxes
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes

(10)

Income Taxes

The Company’s earnings before income tax expense consists of the following:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2022

 

 

2021

 

 

2020

 

U.S. operations

 

$

(48,311

)

 

$

71,900

 

 

$

(112,671

)

Foreign operations

 

 

570,568

 

 

 

497,857

 

 

 

267,400

 

Earnings before income taxes

 

$

522,257

 

 

$

569,757

 

 

$

154,729

 

 

Income tax consists of the following:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2022

 

 

2021

 

 

2020

 

Current

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

256

 

 

$

34,288

 

 

$

(30,094

)

State

 

 

9,564

 

 

 

7,268

 

 

 

3,841

 

Foreign

 

 

84,904

 

 

 

102,062

 

 

 

56,530

 

 

 

 

94,724

 

 

 

143,618

 

 

 

30,277

 

Deferred

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

7,043

 

 

 

(27,074

)

 

 

(2,208

)

State

 

 

(1,287

)

 

 

(4,481

)

 

 

(3,070

)

Foreign

 

 

(7,385

)

 

 

(357,938

)

 

 

(16,497

)

 

 

 

(1,629

)

 

 

(389,493

)

 

 

(21,775

)

Income tax expense (benefit)

 

$

93,095

 

 

$

(245,875

)

 

$

8,502

 

 

Income taxes differ from the statutory tax rates as applied to earnings before income taxes as follows:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2022

 

 

2021

 

 

2020

 

Expected income tax expense

 

$

109,674

 

 

$

119,649

 

 

$

32,493

 

State income tax, net of federal benefit

 

 

(1,597

)

 

 

(172

)

 

 

(2,394

)

Rate differential on foreign income

 

 

(49,175

)

 

 

(24,615

)

 

 

(27,426

)

Change in unrecognized tax benefits

 

 

12,310

 

 

 

11,538

 

 

 

6,084

 

Intra-entity intellectual property transfer

 

 

(3,232

)

 

 

(346,776

)

 

 

 

FDII deduction

 

 

 

 

 

(10,695

)

 

 

 

Non-deductible compensation

 

 

13,668

 

 

 

8,693

 

 

 

7,119

 

Tax credits

 

 

(7,544

)

 

 

(7,547

)

 

 

(6,312

)

Excess tax on stock compensation

 

 

1,305

 

 

 

976

 

 

 

703

 

Benefits provided by the Coronavirus Aid, Relief, and Economic Security Act

 

 

 

 

 

(905

)

 

 

(15,863

)

Non-deductible share cancellation

 

 

 

 

 

 

 

 

4,048

 

U.S. tax on foreign earnings

 

 

7,611

 

 

 

 

 

 

 

Other

 

 

217

 

 

 

(927

)

 

 

(463

)

Change in valuation allowance

 

 

9,858

 

 

 

4,906

 

 

 

10,513

 

Income tax expense (benefit)

 

$

93,095

 

 

$

(245,875

)

 

$

8,502

 

Effective tax rate

 

 

17.8

%

 

 

(43.2

)%

 

 

5.5

%

The Company’s income tax expense (benefit) and effective income tax rate are significantly impacted by the mix of the Company’s domestic and foreign earnings (loss) before income taxes. In the non-U.S. jurisdictions in which the Company has operations, the applicable statutory rates are generally lower than in the U.S., ranging from 0.0% to 34.0%. The Company’s income tax expense (benefit) was calculated using the applicable rate for each jurisdiction applied to the Company’s pre-tax earnings (loss) while the Company’s effective tax rate is calculated by dividing income tax expense (benefit) by earnings before income taxes. For 2022, the effective tax rate was lower than the U.S. federal and state combined statutory rate of approximately 25%, primarily due to tax benefits related to earnings from foreign operations in jurisdictions imposing either lower tax rates on corporate earnings or no corporate income tax.

The Company is subject to a tax on global intangible low-taxed income (“GILTI”). GILTI taxes foreign income in excess of a deemed return on tangible assets of foreign corporations and is treated as a period cost.

The tax effects of temporary differences giving rise to deferred tax assets and liabilities are presented below:

 

 

 

As of December 31,

 

(in thousands)

 

2022

 

 

2021

 

Deferred tax assets

 

 

 

 

 

 

 

 

Inventory adjustments

 

$

10,810

 

 

$

9,099

 

Accrued expenses

 

 

92,215

 

 

 

76,412

 

Allowances for bad debts and chargebacks

 

 

4,728

 

 

 

4,667

 

Advance payment

 

 

6,339

 

 

 

27,594

 

Intra-entity IP transfer

 

 

343,106

 

 

 

346,776

 

Section 174 Capitalized Costs

 

 

15,721

 

 

 

 

Loss carryforwards

 

 

50,558

 

 

 

38,273

 

Business credit carryforward

 

 

25,289

 

 

 

15,537

 

Share-based compensation

 

 

7,725

 

 

 

6,479

 

Operating lease liabilities

 

 

317,449

 

 

 

337,399

 

Valuation allowance

 

 

(58,321

)

 

 

(48,463

)

Total deferred tax assets

 

 

815,619

 

 

 

813,773

 

Deferred tax liabilities

 

 

 

 

 

 

 

 

Prepaid expenses

 

 

5,073

 

 

 

4,116

 

Right-of-use assets

 

 

317,449

 

 

 

337,371

 

Depreciation on property, plant and equipment

 

 

47,563

 

 

 

32,751

 

Total deferred tax liabilities

 

 

370,085

 

 

 

374,238

 

Net deferred tax assets

 

$

445,534

 

 

$

439,535

 

 

At December 31, 2022, combined foreign net operating loss carry-forwards were approximately $176.7 million of which $3.7 million expire in 2023 and $34.3 million can be carried forward indefinitely. A valuation allowance of $58.3 million is recorded for the amount of deferred tax assets which is not likely to be fully utilized. The $9.9 million increase in the valuation allowance primarily relates to increases in deferred tax assets in certain foreign non-benefited loss jurisdictions.

In December 2021, the Company completed an intra-entity transfer of certain intellectual property rights to Switzerland primarily to align with current and future international operations. The transfer resulted in a step-up in the Swiss tax basis of intellectual property rights and a correlated increase in foreign deferred tax assets, based on the estimated fair value of the transferred intellectual property rights to be amortized. As a result, the Company recorded a tax benefit of $346.8 million, net of uncertain tax positions of $25.2 million. In 2022, the company obtained a tax ruling on the fair value of the transferred intellectual property rights, resulting in a settlement of the uncertain tax position and an adjusted recorded tax benefit of $349.6 million.

U.S. federal and net operating loss carry-forwards at December 31, 2022 was $35.0 million which can be carried forward indefinitely. U.S. federal tax credit carry-forward at December 31, 2022 was 12.6 million. State tax credit and net operating loss carry-forwards at December 31, 2022 were $15.4 million and $43.4 million. These tax credit and net operating loss carry-forward amounts begin to expire in 2030. No valuation allowance has been recorded, as the Company believes they will be fully utilized.

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

 

 

 

As of December 31,

 

(in thousands)

 

2022

 

 

2021

 

Beginning balance

 

$

66,951

 

 

$

21,511

 

Additions for current year tax positions

 

 

5,345

 

 

 

34,975

 

Additions for prior year tax positions

 

 

4,616

 

 

 

15,256

 

Reductions for prior year tax positions

 

 

(674

)

 

 

(361

)

Settlement of uncertain tax positions

 

 

(32,954

)

 

 

(812

)

Reductions related to lapse of statute of limitations

 

 

(2,037

)

 

 

(3,618

)

Ending balance

 

$

41,247

 

 

$

66,951

 

 

Current unrecognized tax benefits are recorded as a reduction in prepaid expense and included in tax expense when recorded. Long-term unrecognized tax benefits are recorded as an increase in long-term taxes payable with a portion included in tax expense and a portion recorded as a reduction in deferred tax liabilities when recorded. If recognized, $29.4 million of unrecognized tax benefits would be recorded as a reduction in income tax expense, and $11.8 million would be recorded as an increase in deferred tax liabilities.

The amount of income taxes the Company pays is subject to ongoing audits by taxing jurisdictions around the world. The Company’s estimate of the potential outcome of any uncertain tax position is subject to its assessment of relevant risks, facts, and circumstances existing at that time. The Company believes that it has adequately provided for these matters. However, the Company’s future results may include favorable or unfavorable adjustments to its estimates in the period the audits are resolved, which may impact the Company’s effective tax rate.

The Company estimates interest and penalties related to income tax matters which are included in income tax expense (benefits). Amounts were $(1.9) million, $3.6 million, and $0.3 million for the years ended December 31, 2022, 2021, and 2020. Accrued interest and penalties were $4.2 million and $6.2 million as of December 31, 2022 and 2021.

As of December 31, 2022, the Company’s tax filings are generally subject to examination in the U.S. and most foreign jurisdictions for years ending on or after December 31, 2018, and in several Asian and European tax jurisdictions for years ending on or after December 31, 2012. During the year, the Company reduced the balance of unrecognized tax benefits by $2.0 million as a result of expiring statutes and $33.0 million from the settlements and decision on a foreign tax ruling. The Company also released $2.3 million in interest during the year. It is reasonably possible that certain domestic and foreign statutes will expire and certain domestic and foreign audits will be settled during the next twelve months which would reduce the balance of 2022 and prior year unrecognized tax benefits by $1.2 million and $2.3 million.

The Company’s cash and cash equivalents held in the U.S. and cash provided from operations are sufficient to meet the Company’s liquidity needs in the U.S. for the next twelve months. However, the Company may repatriate certain funds held outside the U.S. for which all applicable U.S. and non-U.S. tax has been fully provided as of December 31, 2022. The Company has provided for the tax impact of expected distributions from its joint venture in China as well as from its subsidiary in Chile to its intermediate parent company in Switzerland. Otherwise, because of the need for cash for operating capital and continued overseas expansion, the Company does not foresee the need for any of its other foreign subsidiaries to distribute funds up to an intermediate foreign parent company in any form of taxable dividend. Under current applicable tax laws, if the Company chooses to repatriate some or all of the funds the Company has designated as indefinitely reinvested outside the U.S., the amount repatriated would not be subject to federal income tax but may be subject to applicable non-U.S. income and withholding taxes, and to certain state income taxes. In addition to certain tax restrictions, our joint venture in China has limitations on its distribution of earnings, as local law currently requires it to maintain $25.9 million of its earnings in a statutory reserve.